Poster Presentations

P1
Regulation of PS2, CCND1 & IEX-1 genes in HER2-overexpressing breast cancer cells: Correlation with tamoxifen resistance
X. Alexi, C. Gouedard, P. Mylona, D.J. Mitsiou, M.N. Alexis

P2
Cytometric characterization of tumor cell dissemination patterns in preclinical models of breast cancer metastasis
D. Goodale, C. Phay, C.O. Postenka, M. Keeney, A.L. Allan

P3
Implementation of a single cell sorting process for realtime PCR without preamplification
V. Auner, S. Tveito, O. Fodstad, A. Plaschke-Schluetter, R. Zeillinger

P4
A Xenograft Assay to Functionally address the Malignancy of Human Disseminated Tumor Cells
I. Baccelli, N. Riggi, S. Offner, S. Riethdorf, C. Manz, K. Pantel, A. Trumpp

P5
Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells
M. Balic, N. Rapp, J. Strutz, H. Lin, S. Stanzer, J. Szkandera, H. Samonigg,
R.J. Cote, N. Dandachi

P6
KRAS2 mutation analysis in serum samples surrogates tumour tissue.
T. Bauernhofer, N. Dandachi, B. Rupp, M. Stefan, T. Maierhofer, G. Höfler, C. Guelly, M. Otte

P7
Phenotypical and molecular characterization of circulating tumor cells after Cell Search processing
C. Beneken, S. Langer, C. Panabières, O. Mauermann, S. Meyer-Staeckling, B. Brandt, K. Pantel, S. Riethdorf

P8
CirCe07 now started: an observational study of CTC in locally-advanced pancreatic cancers
F.C. Bidard, C. Mathiot, J.Y. Pierga, F. Huguet, C. Louvet, P. Hammel

P9
Inverse correlation of disseminated tumor cells and pretreatment mri findings in PN+M0 prostate cancer
W. Lilleby, E. Borgen, K. Hole, R. Fjelldal, I. Hellerud, J. Nesland

P10
Performance of adnatest for CTC detection in breast cancer patients. Comparison to other CTC detection methods
E. Borgen, M.C. Rypdal, S. Hauch, W.Albert, C.B. Schirmer, I. Stav Johanssen,
B. Naume, K. Andersland, J.M. Nesland.

P11
A QPCR-based circulating tumor cell detection platform predicts survival in breast cancer patients
A.J. Bosma, T.J. Molloy (L. Baumbusch, E. Borgen, B. Naume, L.J. van't Veer

P12
Cells with characteristics of cancer stem cells express CD133 and CXCR4 in human ovarian cancer
M. Cioffi, R. Camerlingo, C. Consales, C. D'Alterio, S. Greggi, S. Pignata, G. Castello, G. Pirozzi, S. Scala

P13
Specific detection of circulating tumor cells in women with breast cancer: Introduction of a multi-marker platform for early detection and monitoring of metastasis
A. de Albuquerque, S. Kaul, G. Breier, G. Stamminger, N. Fersis

P14
Circulating tumor cell detection in advanced non small cell lung cancer
L.A. Devriese, A.J. Bosma, M.M. van den Heuvel, M. Hauptmann, L.J. van't Veer, J.H.M. Schellens

P15
Clinical relevance of early disseminated breast cancer cells depends on their cytokeratin expression pattern
K.E. Effenberger, E. Borgen, C. zu Eulenburg, K. Bartkowiak, A. Grosser,
M. Synnestvedt, R. Kaaresen, B. Brandt, J.M. Nesland, K. Pantel, B. Naume

P16
Clinical strength of the l-dopa decarboxylase (DDC) gene in early detecting human gastric carcinomas
D. Florou, I.N. Papadopoulos, E.G. Fragoulis, A. Scorilas

P17
Biomarker discovery in low-grade breast cancer tissue biopsies using a novel quantitative proteomic approach
T. Roumeliotis, P. Bouchal, R. Hrstka, R. Nenutil, B. Vojtesek,
S.D. Garbis

P18
Genomic profiling of colorectal cancers from patients diagnosed with circulating tumor cells
S.A. Joosse, C. Beneken, C. Alix-Panabières, M. Nieuwland, R.M. Kerkhoven, E. Deneve, J. Ramos, L. Riethdorf, S. Riethdorf, K. Pantel,
J. Hannemann

P19
Molecular marker development for characterization of circulating tumor cells in breast and prostate cancer
L.E. Lowes, B.D. Hedley, M. Keeney, A.L. Allan

P20
Dose dependent effects of G-CSF on CA 27.29 in early stage breast cancer patients
P. Hepp, B. Rack, C. Schindlbeck, J. Jückstock, C. Jendereck, A. Andergassen, E. Genss, S. Sommer, K. Friese, W. Janni

P21
The clinical significance of VIM expression in gastric cancer cells in bone marrow
M. Iwatsuki, K. Mimori, H. Baba, M. Mori

P22
Interactions of breast cancer cells with the microenvironment of the human bone marrow
T. Kaiser, G. Klein, D. Wallwiener, T. Fehm

P23
Distinct expression of twist and vimentin in CTCs of early and metastatic breast cancer patients
G. Kallergi, M. A. Papadaki, S. Agelaki, D. Mavroudis, V. Georgoulias

P24
Angiogenesis associated molecules are expressed in CTCs of breast cancer patients
G. Kallergi, H. Markomanolaki, V. Giannoukaraki, M. A. Papadaki, A. Strati, E. Lianidou, V. Georgoulias, D. Mavroudis, S. Agelaki

P25
Gene expression profiling of circulating tumor cells in breast cancer patients
K. Kolostova, D. Pinterova, V. Bobek, J. Pavlasek, V. Ctrnacta, V. Rusnakova, A. Tichopad, M. Brychta, M. Kubecova, J. Valchar, I. Janatkova, V. Prokopova, Z. Usiakova, P. Tesarova, S. Kasimir-Bauer, M. Kubista

P26
Development of a microfluidic device to mimic vasculature for studying mechanism of tumor metastasis
H.K. Lin, B. Reese, S. Zheng, B. Evans, C.H. Koh, R.H. Datar, T. Thundat

P27
Inhibition of metastasis on mouse lung adenocarcinoma and melanoma models by mastic oil
S. Magkouta, A. Pyriochou, A. Papapetropoulos, F.N. Kolisis, C. Roussos, H. Loutrari

P28
Detection and characterization of tumour cells in sentinel lymph nodes and bone marrow of patients with breast cancer
G.M. Maelandsmo, D. Park, S. Tveito, S. Juell, H.T.N. Le, I. Dybsjord, F.F. Hussain, H.K. Hoifodt, T. Sauer, R. Karesen, O. Fodstad

P29
A novel method for specific detection of micrometastasis in blood and bone marrow samples
E. Manna, F. Wang, N. Su, Y. Luo, D. Krag

P30
Kinetics of circulating tumor cells in metastatic breast cancer patients.
M. Mego, U. De Giorgi, S. Dawood, E. Andreopoulou, V. Valero, B. Handy, N.T. Ueno, J.M. Reuben, M. Cristofanilli

P31
Estrogen receptor beta isoforms 1 and 2 differentially modulate growth and invasiveness of breast cancer cells in response to estrogen and antiestrogens
A.K. Meligova, N. Chantzi, H. Pratsinis, D.J. Mitsiou and M.N. Alexis

P32
Molecular detection of circulating tumor cells (CTCs) in the peripheral blood of colon cancer patients
A. Mourtzikou, C. Kroupis, M. Skondra, N. Poumpouridou, G. Athanasas,
S. Christodoulou, D. Pectasides, C. Dimas

P33
Molecular markers for tumor cell dissemination in female cancers
E. Obermayr, D. Cacsire Castillo-Tong, F. Sanchez-Cabo, G. Heinze, R. Zeillinger

P34
Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation PNA clamp PCR
S. Oltedal, B. Gilje, H. Korner, O.G. Aasprong, K. Tjensvoll, R. Heikkila, R. Smaaland, O. Nordgard

P35
A novel method for detecting EGFR MRNA transcripts in situ in circulating tumour cells of metastatic breast cancer patients
R. Payne, F. Wang, N. Su, B. Ward, E. Yagüe, Y. Luo, RC. Coombes

P36
Circulating tumor cells and circulating endothelial cells in patients with metastatic breast cancer
D. Peeters, G. Van den Eynden, H. Elst, I. Benoy, S. Van Laere, I. Van der Auwera, X.B. Trinh, R. Limame, P. Huget, P. van Dam, P. Vermeulen, L. Dirix

P37
Prognostic value of disseminated tumor cells in peripheral blood and bone marrow of patients with breast cancer
D. Peeters, I. Benoy, G. Van den Eynden, I. Van der Auwera, S. Van Laere, X.B. Trinh, R. Limame, P. Huget, P. van Dam, P. Vermeulen, L. Dirix

P38
CirCe01 is started: a pivotal trial to demonstrate CTC usefulness in advanced metastatic breast cancer
F.C. Bidard, F. Andre, E. Brain, M. Espie, N. Tubiana-Mathieu, T. Bachelot, M. Campone, C. Mathiot, V. Dieras, B. Asselain, C. Bouleuc, L. Copel, J.Y. Pierga

P39
Comparative study of the cell search system and real time reverse transcription polymerase chain reaction (RT-PCR) for CK 19 MRNA in detecting circulating tumor cells (CTCS) in the blood of metastatic breast cancer (MBC) patients
E. Politaki, S. Apostolaki, M. Perraki, G. Saloustrou, S. Aggelaki, V. Georgoulias,
D. Mavroudis

P40
In vitro and in vivo functional characterization of new cycle-peptides inhibitors for C-X-C chemokine receptor-4 (CXCR4)
L. Portella, M. Napolitano, C. Consales, C. D'Alterio, M. Polimero, M. Cioffi, R.M. Vitale, P. Amodeo, S. De Luca, L. Monfregola, G. Castello, S. Scala

P41
Evaluation of minimal residual disease (MRD) in acute promyelocytic leukemia (APL) using multiparameter flow cytometry (MFC)
K. Psarra, I. Grigoriou, M. Garofalaki, M. Pagoni, I. Tziotziou, H. Rinota, K. Manaka, E. Nikolou, V. Kapsimali, C. Papasteriades

P42
Pathologic study results of 100 cervical lymphadenoctomy patients in the pathology ward of fatemi hospital in ardabil from 2004-2008
M.M. Chinifroush.asl, E. Rezaei Ghalechi

P43
Detection and characterization of circulating tumor cells in patients with advanced non-metastatic bladder cancer
S. Riethdorf, M. Rink, O. Mauermann, S. Minner, S. Langer, F.K.H. Chun, H. Heinzer, M. Fisch, K. Pantel

P44
Single circulating tumour cell molecular characterization: A feasibility study
G. Bonizzi, K. Goerner, L. Zorzino, A. Waldenmaier, R. Kirchner, M.C. Cassatella, F. Nole, P.G. Pelicci, E. Allievi, M. Alunni-Fabbroni, M.T. Sandri

P45
Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer
H. Schwarzenbach, C. Alix- Panabières, I. Muller, N. Letang, J.P. Vendrell, X. Rebillard, K. Pantel

P46
Detection of circulating tumor cells in the context of treatment
M.J. Serrano, P. Sánchez Rovira, A. Fernández, J.A. Lorente

P47
Chlamydia trachomatis and cervical intraepithelial neoplasia in a Middle Eastern community
M. Valadan, F. Yarandib, Z. Eftekharb, S. Darvishc, M. Sheikh Fathollahid, A. Mirsalehiane, M. Bandegi

P48
Predictive and prognostic value of peripheral blood CEA mRNA-positive cells detected by real-time polymerase chain reaction in patients with early-operable colorectal cancer (CRC)
N. Vardakis, Ip. Messaritakis, Ch. Papadaki, M. Sfakianaki, G. Agoglossakis, M. Peraki, S. Apostolaki, D. Hatzidaki, J. Koutroubakis, D. Mavroudis, V. Georgoulias,
J. Souglakos

P49
Identification of Target Genes in Micrometastatic Lung Cancer by Methylation Arrays
H. Wikman, M. Kraemling, J.R. Izbicki, D. Kemming, K. Pantel

P50
Circulating tumor cell (CTC) and endothelial cell (CEC) as a diagnostic marker in malignant pleural mesothelioma
K. Yoneda, F. Tanaka, N. Kondo, M. Hashimoto, T. Takuwa, S. Matsumoto, Y. Okumura, A. Sato, T. Tsujimura, K. Fukuoka, T. Nakano, S. Hasegawa

P51
Enrichment of circulating tumor cells from a large blood volume by leukapheresis and elutriation: proof of concept
R.L. Eifler, J. Lind, M.B. Fischer, V. Weber, D. Falkenhagen, R. Zeillinger

P52
Expression of EMT regulators TWIST1, SNAIL and VIMENTIN in non-small cell lung cancer (NSCLC) by quantitative RT-PCR
N. Konstantinidou, A. Strati, E.G. Tsaroucha, L. Kaklamanis, E.S Lianidou

P53
Expression of EMT regulator TWIST-1 in cervical cancer by quantitative RT-PCR
N. Konstantinidou, A. Strati, E.Varhalama , E.S Lianidou

P54
Expression of mature miR-21 and let-7a in CTCs of breast cancer patients with verified metastasis
A. Markou, A. Strati, N. Malamos, V. Georgoulias, E.S Lianidou

P55
Prognostic significance of DNA methylation markers in tissues and corresponding cell-free circulating DNA in plasma of NSCLC patients
I. Balgkouranidou, P. Triantafyllou, C. Theodoropoulos, E.G. Tsaroucha,
L. Kaklamanis, E. Lianidou

P56
DNA methylation of the tumor suppressor gene CST6 in Circulating Tumor Cells (CTCs) of breast cancer patients
A. Tzitzira, A. Strati, G. Sotiropoulou, N. Malamos, V. Georgoulias, E.S. Lianidou

P57
Detection of CST6 promoter methylation in cell-free DNA circulating in plasma of operable breast cancer patients
A. Tzitzira, M. Kioulafa, G. Sotiropoulou, N. Malamos, V. Georgoulias, E.S. Lianidou

P58
MicroRNA-21 expression levels are accompanied by respective alterations in PDCD4 protein levels in non-small cell lung cancer
I.S. Sourvinou, A. Markou, L. Kaklamanis, E.G. Tsaroucha, I. Ozaki, S. Matsuhashi, E.S. Lianidou

P59
Evaluation of a novel Cytokeratin-19 (CK-19) Quantification kit for the detection of circulating tumor cells (CTCs) in peripheral blood of early breast cancer patients
A. Strati, A. Markou, A. Stathopoulou, D. Mavroudis, V. Georgoulias, E.S. Lianidou

P60
DTC and the risk of loco-regional recurrence in non metastatic breast cancer
F.C. Bidard, Y.M. Kirova, A. Vincent-Salomon, S. Alran, Y. de Rycke, B. Sigal-Zafrani, X. Sastre-Garau, L. Mignot, A. Fourquet, J.Y. Pierga 

P61
Enumeration of rare cells in a multistage magnetic microfluidic disk by positive selection
K.-C. Chen, Y.-C. Pan, C.-L. Chen, A. M. Wo

P62
Error estimation of CETC measurements - between experimental variance and stochastic error
T.C. Kroll, K. Pachmann

P63
Single CTC detection and overall survival in non metastatic breast cancer
F.C. Bidard, C. Mathiot, E. Brain, S. Delaloge, S. Giachetti, R. Salmon, L. Mignot, A. Vincent-Salomon, M. Marty, J.Y. Pierga 

P64
Evaluation of flow cytometry for the detection of circulating tumor cells
K. Dagla, V. Kapsimali, C. Papasteriades, S. Spyridakis, E. Lianidou, K. Psarra

P65
A pilot study to evaluate the efficacy of gefitinib in eliminating circulating chemo-and hormone-resistant cytokeratin-positive tumour cells in women with metastatic breast cancer
A. Kalykaki, S. Agelaki, G. Kallergi, K. Kalbakis, D. Mavroudis, V. Georgoulias